Whitaker Myers Wealth Managers LTD. Buys 652 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Whitaker Myers Wealth Managers LTD. raised its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 167.6% in the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,041 shares of the biotechnology company's stock after buying an additional 652 shares during the quarter. Whitaker Myers Wealth Managers LTD.'s holdings in Axon Enterprise were worth $548,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Fourth Dimension Wealth LLC purchased a new position in shares of Axon Enterprise in the fourth quarter worth about $30,000. Elequin Capital LP acquired a new stake in shares of Axon Enterprise in the fourth quarter worth approximately $46,000. Stonebridge Financial Group LLC acquired a new stake in shares of Axon Enterprise in the fourth quarter worth approximately $53,000. CoreFirst Bank & Trust acquired a new stake in shares of Axon Enterprise in the fourth quarter worth approximately $59,000. Finally, Global Financial Private Client LLC lifted its position in Axon Enterprise by 11,100.0% during the first quarter. Global Financial Private Client LLC now owns 112 shares of the biotechnology company's stock worth $59,000 after buying an additional 111 shares in the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the company. Barclays upped their price target on Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a research note on Friday, May 9th. Craig Hallum cut Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. Northcoast Research cut Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 19th. The Goldman Sachs Group upped their target price on Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a research report on Wednesday, May 14th. Finally, Needham & Company LLC increased their price objective on Axon Enterprise from $600.00 to $750.00 and gave the stock a "buy" rating in a research report on Thursday, May 8th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have given a buy rating to the company's stock. Based on data from MarketBeat.com, Axon Enterprise has a consensus rating of "Moderate Buy" and a consensus target price of $699.55.

Insider Buying and Selling

In related news, CRO Cameron Brooks sold 3,000 shares of the firm's stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $740.76, for a total value of $2,222,280.00. Following the completion of the sale, the executive now owns 19,447 shares of the company's stock, valued at $14,405,559.72. This trade represents a 13.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Michael Garnreiter sold 87 shares of the firm's stock in a transaction that occurred on Tuesday, June 3rd. The shares were sold at an average price of $760.00, for a total transaction of $66,120.00. Following the completion of the transaction, the director now directly owns 24,653 shares in the company, valued at approximately $18,736,280. The trade was a 0.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 43,969 shares of company stock worth $29,909,594. Corporate insiders own 4.40% of the company's stock.

Axon Enterprise Stock Performance

Shares of AXON stock opened at $791.85 on Friday. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The business has a 50 day moving average of $643.89 and a two-hundred day moving average of $616.49. The company has a market cap of $61.65 billion, a P/E ratio of 204.61, a PEG ratio of 5.17 and a beta of 1.29. Axon Enterprise, Inc. has a 52 week low of $278.24 and a 52 week high of $798.16.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.34 by $0.07. Axon Enterprise had a return on equity of 7.50% and a net margin of 15.37%. The company had revenue of $603.63 million for the quarter, compared to analysts' expectations of $585.67 million. During the same quarter in the prior year, the company earned $1.15 earnings per share. The firm's revenue was up 31.3% on a year-over-year basis. As a group, analysts anticipate that Axon Enterprise, Inc. will post 5.8 EPS for the current year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.